MIMRYLO
NDC 63020-725, rusfertide, kit, from Takeda Pharmaceuticals America, Inc..
- Product NDC
- 63020-725
- Status
- Listed
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Dosage form
- KIT
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA220605
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63020-725 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63020-725-20 | 63020072520 | 1 KIT in 1 CARTON (63020-725-20) * 19 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (63020-720-20) * .6 mL in 1 SYRINGE (63020-600-05) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/101aff01-31ed-4841-a8b6-0a5a8503189b
Use it
Look up 63020-725 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63020-725 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63020-725. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.